Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir in Pregnancy (TiP) Study
NCT01125696Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- May 2012
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in human immunodeficiency virus infection (HIV) and hepatitis B (HBV) comparing Tenofovir Arm with Standard of Care Arm (2 arms). Primary endpoints: Tenofovir Safety for mothers measured by incidence of serious adverse events (SAEs), Dual Energy X-ray absorptiometry (DXA) scans of bone mineral density and 3 more. Started May 2012; status: completed.
02
Drugs
tenofovir
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01125696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125696.